Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.75 EUR | +5.44% | +6.31% | +8.88% |
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.88% | 33.47B | - | ||
-5.50% | 4.19B | B+ | ||
+13.82% | 1.4B | D | ||
+26.69% | 1.33B | - | - | |
-5.06% | 1.31B | - | - | |
-20.83% | 819M | - | ||
-22.93% | 758M | - | - | |
-20.23% | 712M | - | ||
-35.33% | 678M | - | ||
-19.06% | 617M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HEN3 Stock
- HEN Stock
- Ratings Henkel AG & Co. KGaA